DNA vaccine delivered by a needle-free injection device improves potency of priming for antibody and CD8+ T-cell responses after rAd5 boost in a randomized clinical trial
about
Vaccination with human papillomavirus pseudovirus-encapsidated plasmids targeted to skin using microneedlesEffect of vaccine administration modality on immunogenicity and efficacy.Efficient vaccine against pandemic influenza: combining DNA vaccination and targeted delivery to MHC class II molecules.Molecular mechanisms for enhanced DNA vaccine immunogenicity.Phase 1 study of pandemic H1 DNA vaccine in healthy adultsThe influence of delivery vectors on HIV vaccine efficacyHomologous boosting with adenoviral serotype 5 HIV vaccine (rAd5) vector can boost antibody responses despite preexisting vector-specific immunity in a randomized phase I clinical trial.Phase I randomized clinical trial of VRC DNA and rAd5 HIV-1 vaccine delivery by intramuscular (i.m.), subcutaneous (s.c.) and intradermal (i.d.) administration (VRC 011)Effect of rAd5-Vector HIV-1 Preventive Vaccines on HIV-1 Acquisition: A Participant-Level Meta-Analysis of Randomized TrialsSuccessive site translocating inoculation potentiates DNA/recombinant vaccinia vaccinationCryJ-LAMP DNA Vaccines for Japanese Red Cedar Allergy Induce Robust Th1-Type Immune Responses in Murine ModelToll-Like Receptor 9 Activation Rescues Impaired Antibody Response in Needle-free Intradermal DNA VaccinationBroad-spectrum anti-tumor and anti-metastatic DNA vaccine based on p62-encoding vector.Needle-free delivery of macromolecules through the skin using controllable jet injectors.Recent Developments in Preclinical DNA Vaccination.DNA Immunization for HIV Vaccine Development.MultiTEP platform-based DNA epitope vaccine targeting N-terminus of tau induces strong immune responses and reduces tau pathology in THY-Tau22 mice.Modified Vaccinia virus Ankara-based vaccines in the era of personalized immunotherapy of cancer.Characterization of T-cell responses to cryptic epitopes in recipients of a noncodon-optimized HIV-1 vaccineAn avian influenza H7 DNA priming vaccine is safe and immunogenic in a randomized phase I clinical trial.Codon optimization and improved delivery/immunization regimen enhance the immune response against wild-type and drug-resistant HIV-1 reverse transcriptase, preserving its Th2-polarity.A Review of DNA Vaccines Against InfluenzaDNA vaccines against tuberculosisOne Group's Historical Reflections on DNA Vaccine Development
P2860
Q27311290-85E197E6-977D-42D8-8651-6FFC526A2821Q27692376-9A07A670-5DC1-4286-8239-22E3836FDDCFQ30204348-6B31DE95-AF03-4C99-9129-647D0CA9BEB9Q30366743-580A4EB9-7EF7-4EFF-AE21-DF57DF90990FQ30373824-EDD1652B-C58C-4F15-A187-AA3F6D536F45Q34077543-59F05FA0-52B8-401C-949F-9C7BDBD4B9F1Q34263835-F9DACAE5-EC84-479D-AB6E-28B4C29E66FAQ35118834-F8E56715-5577-4BE3-81EB-CDB7D7E428F8Q35762443-5A9502D5-7C8C-46E2-8F45-CF3418148622Q36369631-2C498A8A-B835-4488-A48F-EDC7BD2FD1F7Q36901422-19A741E7-D5AD-4E75-960E-231A964DD24BQ37277900-ECB322A8-8760-4CEC-A589-9ACA1BB6C4EBQ37381632-6C907C1A-7CBE-4AEE-9D9C-7DFC70462A2FQ38500859-3A85A17A-3AA5-4CCB-B9AB-3E7CA87143AEQ38581976-E06DB2D0-86F9-480D-BF41-79FDDE279CD7Q38581981-E8245FF1-1EAE-4508-94FD-BB6E8E736566Q38892738-F89B6775-A544-4BED-878A-B8A824C79292Q40068135-792F29E6-F518-48D7-84C9-8E5F81B4BD9FQ41881198-EF429955-C26C-4420-A8A9-FABCB14D524BQ47105782-34BC84FD-FF50-4C0B-AD66-2428AF2B834DQ55154648-A9F5C484-8E90-4F8F-B992-7E5A364E66C1Q57094261-A95D9D45-A7DC-42D9-83AA-5C4DD4919C0FQ57203104-14A335D8-28D3-4495-9539-9EF94CAB1B66Q58731456-F91D6A75-5F00-478C-911F-D90932781240
P2860
DNA vaccine delivered by a needle-free injection device improves potency of priming for antibody and CD8+ T-cell responses after rAd5 boost in a randomized clinical trial
description
2013 nî lūn-bûn
@nan
2013 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
DNA vaccine delivered by a nee ...... in a randomized clinical trial
@ast
DNA vaccine delivered by a nee ...... in a randomized clinical trial
@en
DNA vaccine delivered by a nee ...... in a randomized clinical trial
@nl
type
label
DNA vaccine delivered by a nee ...... in a randomized clinical trial
@ast
DNA vaccine delivered by a nee ...... in a randomized clinical trial
@en
DNA vaccine delivered by a nee ...... in a randomized clinical trial
@nl
prefLabel
DNA vaccine delivered by a nee ...... in a randomized clinical trial
@ast
DNA vaccine delivered by a nee ...... in a randomized clinical trial
@en
DNA vaccine delivered by a nee ...... in a randomized clinical trial
@nl
P2093
P2860
P50
P1433
P1476
DNA vaccine delivered by a nee ...... in a randomized clinical trial
@en
P2093
Ingelise J Gordon
Mario Roederer
Martha C Nason
Mary E Enama
Richard A Koup
Robert T Bailer
Sarah A Plummer
Sheila A Peel
VRC 008 Study Team
P2860
P304
P356
10.1371/JOURNAL.PONE.0059340
P407
P577
2013-04-08T00:00:00Z